机构

• 上海药物研究所 [198]
• 合肥物质科学研究院 [67]
• 上海生物化学与细胞... [46]
• 近代物理研究所 [45]
• 上海营养与健康研究... [36]
• 长春应用化学研究所 [29]
• 更多

采集方式

• OAI收割 [707]
• iSwitch采集 [29]

内容类型

• 期刊论文 [702]
• 学位论文 [21]
• 会议论文 [12]
• 其他 [1]

发表日期

• 2024 [4]
• 2023 [17]
• 2022 [46]
• 2021 [54]
• 2020 [60]
• 2019 [61]
• 更多

学科主题

• Oncology [23]
• Cell Biol... [11]
• Biochemist... [9]
• Science & ... [9]
• 物理化学 [9]
• Pharmacolo... [5]
• 更多

筛选

浏览/检索结果: 共736条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma 期刊论文  OAI收割 CLINICAL PROTEOMICS, 2024, 卷号: 21, 期号: 1, 页码: 11 作者:  Huang, Yuqi;  Ma, Sheng;  Xu, Jun-Yu;  Qian, Kun;  Wang, Yaru   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/02/19 Lung adenocarcinoma  Proteome  Benign lung disease cases  Solid pathological subtype  Prognostic biomarker   Discovery of GPX4 inhibitors through FP-based high-throughput screening 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 265, 页码: 14 作者:  Cao, Yu;  Wu, Bin;  Xu, Ying;  Wang, Mingchen;  Wu, Xinyu   |  收藏  |  浏览/下载：22/0  |  提交时间：2024/02/27 GPX4 inhibitor  HTS assay  Ferroptosis  Fluorescence polarization   JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers 期刊论文  OAI收割 CANCER LETTERS, 2024, 卷号: 582, 页码: 15 作者:  Lu, Xuxiu;  Yu, Rilei;  Li, Zhen;  Yang, Mengke;  Dai, Jiajia   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/07 Acquired resistance  Cancer  NSCLC  JC-010a  SHP2   Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10 作者:  Ma, Xiao-yu;  Chen, Man-man;  Meng, Ling-hua   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/02/27 CDNs  2'3'-cGAMP  cGAS-STING  tumor microenvironment  ENPP1  TREX1   Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12 作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/01/26 osimertinib resistance  targeted drug delivery  liposomes  panobinostat  tumor-associated macrophage  combination therapy   Physiological and Pathological Functions of TRPM7 Channel and Its Small-molecule Modulators 期刊论文  OAI收割 PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 卷号: 50, 期号: 12, 页码: 2856-2868 作者:  Wang, Yun-Qi;  Guan, Zi-Yue;  Gao, Zhao-Bing;  Zheng, Yue-Ming   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/04/09 TRPM7  ion channel  physiological function  disease  small molecule modulators   Exosomes: New Insights into the Pathogenesis of Metabolic Syndrome 期刊论文  OAI收割 BIOLOGY-BASEL, 2023, 卷号: 12, 期号: 12, 页码: 14 作者:  Wang, Ning;  Li, Jing;  Hu, Zixuan;  Ngowi, Ebenezeri Erasto;  Yan, Baolong   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/02/27 exosome  biogeneration  function  metabolic syndrome   Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives 期刊论文  OAI收割 JOURNAL OF CONTROLLED RELEASE, 2023, 卷号: 362, 页码: 97-120 作者:  Cheng, Zhongquan;  Shang, Jihuan;  Wang, Huarong;  Yu, Leyi;  Yuan, Zhu   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/11/16 Extracellular vesicles  Molecular imaging  Cancer  Diagnosis  Therapy   LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter 期刊论文  OAI收割 BMC CANCER, 2023, 卷号: 23, 期号: 1, 页码: 20 作者:  Ren, Ganglin;  Li, Hongyan;  Hong, Dan;  Hu, Fangyu;  Jin, Rongjia   |  收藏  |  浏览/下载：6/0  |  提交时间：2023/12/08 LINC00955  Colorectal cancer  Cell cycle  CDK2  PHIP  Sp1   Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines 期刊论文  OAI收割 BIOCHEMICAL PHARMACOLOGY, 2023, 卷号: 215, 页码: 14 作者:  Xu, Zhuo;  Wang, Hui;  Meng, Qian;  Ding, Yiluan;  Zhu, Mengying   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Otilonium Bromide  Deubiquitinase  USP28  Selective inhibitor